Company / Inventory
ENDRA Life Sciences Inc. Inventory History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$589.6K
FY2020
5-year range
$59.4K / $589.6K
FY2017-FY2020
Trend
+419.8%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory changed +420% YoY in FY2020, a notable deviation from the 3-year average annual change of +147%.
Based on SEC 10-K filings.
$589,620 in FY2020 with a 3-year CAGR of +45.4%.
Improved from $59,444 to $589,620 over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- +45.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +45.4%, indicating consistent growth.
- In FY2020, inventory increased 419.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $589.6K | +419.8% |
| FY2019 | $113.4K | +90.8% |
| FY2018 | $59.4K | -69.0% |
| FY2017 | $191.7K | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026